Pei-Ling Lee

Title: Pei-Ling Lee: Innovator in Angiotensin II Receptor Antagonists

Introduction

Pei-Ling Lee is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of novel pharmaceutical compounds. His work focuses on creating effective non-peptide antagonists for the angiotensin II receptor, which plays a crucial role in various physiological processes.

Latest Patents

Pei-Ling Lee holds 1 patent for his invention titled "Angiotensin II receptor antagonistic 1,2,4-triazin-5-one derivatives." This patent discloses innovative 1,2,4-triazin-5-one biphenyl derivatives that are useful as non-peptide antagonists of the angiotensin II receptor. The structural formula of these compounds is designed to enhance their efficacy and therapeutic potential.

Career Highlights

Pei-Ling Lee is affiliated with the Development Center for Biotechnology, where he continues to advance research in the field of drug development. His expertise in medicinal chemistry and pharmacology has positioned him as a key figure in the biotechnology sector.

Collaborations

Pei-Ling Lee has collaborated with esteemed colleagues, including Paw-Hwa Yang and Shan-Yen Chou, to further enhance the research and development of innovative therapeutic agents. These collaborations have contributed to the successful advancement of their projects.

Conclusion

Pei-Ling Lee's contributions to the field of biotechnology, particularly through his patent on angiotensin II receptor antagonists, highlight his role as an influential inventor. His work continues to pave the way for new therapeutic options in medicine.